Early Protection of Hamsters Immunized with Attenuated Venezuelan Equine Encephalomyelitis Vaccine

Abstract

The rapid onset and persistence of homologous and heterologous protection induced by attenuated Venezuelan equine encephalomyelitis (VEE) vaccine (TC-83) were studied in the hamster, by using challenge response as the index of protection. At 8 hr postvaccination with 1,000 median immunizing doses of TC-83 vaccine, 15 to 20% of animals were protected against challenge with VEE virus as well as Eastern and Western equine encephalomyelitis viruses. The percentage of protection increased with time postvaccination until 80 to 90% homologous and heterologous protection was achieved by 18 hr postvaccination. Temporal studies indicated that early protection (days 1 to 6) correlated with vaccine viremia, and that the percentage of protection against heterologous challenge decreased with the cessation of viremia. Data are presented to indicate that the early protection phenomenon is one of interference, since little or no replication of a challenge virus occurred when it was administered during the vaccine viremia stage.

Open PDF

Document Details

Document Type
Technical Report
Publication Date
Jun 23, 1972
Accession Number
AD0754508

Entities

People

  • Carl E. Pedersen Jr.
  • David M. Robinson
  • Francis E. Cole Jr.

Organizations

  • United States Army Medical Research Institute of Infectious Diseases

Tags

Communities of Interest

  • Biomedical

DTIC Thesaurus Topics

  • Animals
  • Antibodies
  • Arbovirus Infections
  • Biomedical Research
  • Diseases And Disorders
  • Immunity
  • Immunization
  • Infectious Diseases
  • Intellectual Property
  • Interferon
  • Rodents
  • United States
  • Vaccination
  • Vaccines
  • Venezuelan Equine Encephalomyelitis
  • Virus Diseases
  • Viruses

Fields of Study

  • Biology

Readers

  • Toxicology/Environmental Toxicology
  • Virology (or Medical Virology).

Technology Areas

  • Biotechnology